Molecular Imaging: Page 98

CereMetrix ships quantitative image analysis platform

By AuntMinnie.com staff writers

CereHealth subsidiary CereMetrix has released CereMetrixAI, the second generation of its CereMetrix quantitative imaging and reporting platform.

May 3, 2021

Lantheus subsidiary Exini secures CE Mark for PET/CT prostate software

By AuntMinnie.com staff writers

Lantheus Holdings subsidiary Exini Diagnostics has secured the CE Mark for aPromise, an artificial intelligence software that helps clinicians assess prostate-specific membrane antigen PET/CT exams.

May 2, 2021

CereMark touts patent for PET radiotracer

By AuntMinnie.com staff writers

Pharmaceutical developer CereMark Pharma is highlighting the receipt of a patent for flornaptitril, a PET radiopharmaceutical that the company has licensed from the University of California, Los Angeles.

April 29, 2021

Isotopia backs development of 'virtual' biopsy

By AuntMinnie.com staff writers

Isotopia Molecular Imaging has announced it is backing research led by Israeli investigators who are developing a radiopharmaceutical to detect small, aggressive cancerous tumors.

April 28, 2021

Women and minorities underrepresented in nuclear medicine

By Will Morton

Women and members of racial and ethnic groups are significantly underrepresented in nuclear medicine (NM) in the U.S., according to research published April 25 in the Journal of Nuclear Medicine.

April 28, 2021

Point Biopharma nets NRC OK to operate facility in Ind.

By AuntMinnie.com staff writers

Point Biopharma has received a materials license from the U.S. Nuclear Regulatory Commission (NRC) for its new radioligand manufacturing facility in Indianapolis, IN.

April 27, 2021

New PET tracer may show early pathology of Alzheimer's disease

By Will Morton

A new PET tracer may be effective for visualizing early pathological signs of Alzheimer's disease, according to a study by Swedish researchers that was published April 23 in Molecular Psychiatry.

April 27, 2021

Humana partially reverses PET/CT policy

By AuntMinnie.com staff writers

Humana will begin covering PET/CT imaging for gastric and esophageal oncologic indications, a sign that the modality may be shifting out from under Current Procedural Terminology codes that list it as "experimental/investigational," according to the Society of Nuclear Medicine and Molecular Imaging.

April 27, 2021

FDG-PET/CT may increase survival in SCC patients

By Will Morton

FDG-PET/CT imaging can increase survival rates in patients with newly diagnosed, treatment-naive squamous cell carcinoma (SCC) of the oral cavity, according to a study published online April 21 in JAMA Network Open.

April 26, 2021

SNMMI lands 'Hangover' star Jeong as guest speaker

By Brian Casey

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has announced that comedian Dr. Ken Jeong -- who rose to fame as a kidnapped gangster in "The Hangover" -- will be a guest speaker at the group's 2021 virtual meeting in June.

April 25, 2021

Mediso completes acquisition of MRI spectrometer

By AuntMinnie.com staff writers

Multimodality imaging technology provider Mediso Medical Imaging Systems has purchased the intellectual property of Cameleon4, an MRI spectrometer developed by longtime partner and French spectrometer firm RS2D.

April 25, 2021

Groups launch registry to promote SPECT for prostate cancer

By AuntMinnie.com staff writers

The Oncidium Foundation and Telix Pharmaceuticals have launched a registry to promote the use of SPECT with a prostate-specific membrane antigen agent for prostate cancer detection.

April 20, 2021

Previous Page

Page 98 of 614

Next Page